BioHealth News Archive

Illumina Accelerator Welcomes its Fifth Cycle of Genomic Startups

Illumina Accelerator Welcomes its Fifth Cycle of Genomic Startups

Illumina Accelerator, the genomics-based company creation engine focused on building early stage genomics startups welcomes three new companies to its fifth funding cycle. Since…

Read More

2017 BioHealth Capital Region Forum

Join us as we showcase accomplishments and discuss opportunities for the future of the BioHealth industry in the BioHealth Capital Region. This invitation-only event…

Read More
Startup Professionals Musings: 13 Red Flags To Avoid In Your Investor Funding Pitch

Startup Professionals Musings: 13 Red Flags To Avoid In Your Investor Funding Pitch

After listening to hundreds of startup pitches, and reading even more business plans, most new venture investors develop their own favorite list of “red…

Read More
Organization for rare diseases India (ORDI) – addressing the challenges and opportunities for the Indian rare diseases’ community | Genetics Research | Cambridge Core

Organization for rare diseases India (ORDI) – addressing the challenges and opportunities for the Indian rare diseases’ community | Genetics Research | Cambridge Core

In order to address the unmet needs and create opportunities that benefit patients with rare disease in India, a group of volunteers created a…

Read More
Elon Musk: Humans Need to Merge With Machines to Remain Relevant – Fortune.com

Elon Musk: Humans Need to Merge With Machines to Remain Relevant – Fortune.com

Tesla and SpaceX founder Elon Musk has a suggestion for humans who want to stay relevant in a future of artificial intelligence: merge with…

Read More
Top 10 Brilliant Ideas and Stupid Mistakes: Secrets of Phase II Proposal Success

Top 10 Brilliant Ideas and Stupid Mistakes: Secrets of Phase II Proposal Success

Last month, we outlined our top 10 do's and don'ts for getting your Phase I NIH proposal in shape and ready to submit before…

Read More
Orgenesis Approved for Euro 12.3 Million European Grant for Further Development of Its Type 1 Diabetes Program

Orgenesis Approved for Euro 12.3 Million European Grant for Further Development of Its Type 1 Diabetes Program

Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that its Belgian subsidiary, Orgenesis SPRL, has received the…

Read More
This Technology Could Finally Make Brain Implants Practical

This Technology Could Finally Make Brain Implants Practical

In labs testing how brain implants could help people with physical disabilities, tales of success can be bittersweet. Experiments like those that let a…

Read More
Maryland: The state of research – Maryland Daily Record

Maryland: The state of research – Maryland Daily Record

Which state has the nation’s most research-intensive economy? California? Massachusetts? North Carolina? Actually it’s Maryland. A greater portion of Maryland’s economy comes from private,…

Read More
NHLBI Funding & Research Opportunities and Announcements for February 10, 2017

NHLBI Funding & Research Opportunities and Announcements for February 10, 2017

Funding and Research Opportunities The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of…

Read More
2016 Montgomery County Economic Development Corp Year-End Market Report

2016 Montgomery County Economic Development Corp Year-End Market Report

Hot off the (online) presses: the first annual Year-End Market Report produced by MCEDC. How does the employment rate in Montgomery County compare to…

Read More
Emergent BioSolutions Receives BARDA Task Order Valued at Up to $30.5 Million to Develop Viral Hemorrhagic Fever Therapeutics

Emergent BioSolutions Receives BARDA Task Order Valued at Up to $30.5 Million to Develop Viral Hemorrhagic Fever Therapeutics

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) valued at…

Read More
‘March for Science’ Organizer Says It’s About the Public, Not the Scientists – The Chronicle of Higher Education

‘March for Science’ Organizer Says It’s About the Public, Not the Scientists – The Chronicle of Higher Education

Scientists are no strangers to having their work questioned by lawmakers, and now they are fighting back. On April 22, scientists and their supporters…

Read More
What’s Happening with the Affordable Care Act?

What’s Happening with the Affordable Care Act?

The recent flurry of activity around the Affordable Care Act (ACA) has many people confused about where it stands, and what the employer's obligations…

Read More
Trump’s pick for health and human secretary takes office

Trump’s pick for health and human secretary takes office

President Donald Trump’s new health secretary took office Friday after becoming the latest Cabinet nominee to eke out a confirmation victory in the bitterly…

Read More